(0.11%) 5 252.25 points
(0.07%) 39 670 points
(0.19%) 18 291 points
(0.36%) $78.54
(0.67%) $2.27
(-1.17%) $2 347.30
(-0.62%) $28.33
(-0.07%) $1 006.50
(-0.08%) $0.928
(0.16%) $10.85
(-0.04%) $0.798
(-1.39%) $91.39
@ $11.62
Issued: 14 Feb 2024 @ 13:41
Return: -38.70%
Previous signal: Feb 13 - 15:50
Previous signal:
Return: 25.70 %
Live Chart Being Loaded With Signals
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform...
Stats | |
---|---|
Today's Volume | 362 529 |
Average Volume | 613 472 |
Market Cap | 454.26M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.240 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.48 |
ATR14 | $0.0160 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-16 | Flynn James E | Buy | 1 430 206 | Common Stock |
2024-02-16 | Flynn James E | Buy | 1 430 206 | Common Stock |
2024-02-16 | Flynn James E | Buy | 1 430 205 | Common Stock |
2024-02-14 | Thomas Frank E | Buy | 2 000 | Common Stock |
2024-01-17 | Shankar Gopi | Buy | 135 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 91 transactions |
Buy: 20 937 267 | Sell: 6 152 661 |
Volume Correlation
Larimar Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
FAT | 0.921 |
NSSC | 0.919 |
ADVM | 0.91 |
SRTS | 0.894 |
TYRA | 0.886 |
LXRX | 0.881 |
MORF | 0.879 |
ADP | 0.873 |
PCVX | 0.871 |
ADRE | 0.861 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Larimar Therapeutics Inc Correlation - Currency/Commodity
Larimar Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-311 000 (0.00 %) |
EPS: | $-0.840 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-311 000 (0.00 %) |
EPS: | $-0.840 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-272 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-4.26 |
Financial Reports:
No articles found.
Larimar Therapeutics Inc
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators